BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Gianluca Lopez, Jole Costanza, Matteo Colleoni, Laura Fontana, Stefano Ferrero, Monica Miozzo, Nicola Fusco. Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative TumorsInternational Journal of Molecular Sciences 2019; 20(3): 510 doi: 10.3390/ijms20030510
2
Hong-Da Pan, Yi-Fan Peng, Gang Xiao, Jin Gu. High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasisWorld Journal of Gastroenterology 2017; 23(7): 1233-1240 doi: 10.3748/wjg.v23.i7.1233
3
Fabio Pagni, Elena Guerini-Rocco, Anne Maria Schultheis, Giulia Grazia, Erika Rijavec, Michele Ghidini, Gianluca Lopez, Konstantinos Venetis, Giorgio Alberto Croci, Umberto Malapelle, Nicola Fusco. Targeting Immune-Related Biological Processes in Solid Tumors: We do Need BiomarkersInternational Journal of Molecular Sciences 2019; 20(21): 5452 doi: 10.3390/ijms20215452
4
S.T. Kim, K.C. Banks, E. Pectasides, S.Y. Kim, K. Kim, R.B. Lanman, A. Talasaz, J. An, M.G. Choi, J.H. Lee, T.S. Sohn, J.M. Bae, S. Kim, S.H. Park, J.O. Park, Y.S. Park, H.Y. Lim, N.K.D. Kim, W. Park, H. Lee, A.J. Bass, K. Kim, W.K. Kang, J. Lee. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patientsAnnals of Oncology 2018; 29(4): 1037 doi: 10.1093/annonc/mdy034
5
Masakazu Fujimoto, Ibu Matsuzaki, Masaru Nishino, Yoshifumi Iwahashi, Kenji Warigaya, Fumiyoshi Kojima, Kazuo Ono, Shin-Ichi Murata. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological typesJournal of Clinical Pathology 2018; 71(7): 600 doi: 10.1136/jclinpath-2017-204928
6
Antonio Ieni, Roberta Cardia, Cristina Pizzimenti, Pio Zeppa, Giovanni Tuccari. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different MethodologiesJournal of Personalized Medicine 2020; 10(1): 10 doi: 10.3390/jpm10010010
7
P. García-Alfonso, R. García-Carbonero, J. García-Foncillas, P. Pérez-Segura, R. Salazar, R. Vera, S. Ramón y Cajal, J. Hernández-Losa, S. Landolfi, E. Musulén, M. Cuatrecasas, S. Navarro. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of PathologyClinical and Translational Oncology 2020;  doi: 10.1007/s12094-020-02357-z
8
Maria Diab, Asfar Azmi, Ramzi Mohammad, Philip A. Philip. Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challengesExpert Opinion on Pharmacotherapy 2019; 20(5): 535 doi: 10.1080/14656566.2018.1561869
9
Keita Kai, Yukie Yoda, Atsushi Kawaguchi, Akimichi Minesaki, Hironori Iwasaki, Shinichi Aishima, Hirokazu Noshiro. Formalin fixation on HER-2 and PD-L1 expression in gastric cancer: A pilot analysis using the same surgical specimens with different fixation timesWorld Journal of Clinical Cases 2019; 7(4): 419-430 doi: 10.12998/wjcc.v7.i4.419
10
Pragya Jain, Surbhi Goyal, Geeta Chauhan, Kaushik Majumdar, Shahajad Ali, Puja Sakhuja, AnilK Agarwal. HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic targetIndian Journal of Pathology and Microbiology 2020; 63(2): 214 doi: 10.4103/IJPM.IJPM_664_19
11
Gianluca Lopez, Francesca Boggio, Stefano Ferrero, Nicola Fusco, Alessandro Del Gobbo. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal CarcinomaInternational Journal of Molecular Sciences 2018; 19(10): 3014 doi: 10.3390/ijms19103014
12
Marco Invernizzi, Anna Michelotti, Marianna Noale, Gianluca Lopez, Letterio Runza, Massimo Giroda, Luca Despini, Concetta Blundo, Stefania Maggi, Donatella Gambini, Nicola Fusco. Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of TrastuzumabJournal of Clinical Medicine 2019; 8(2): 138 doi: 10.3390/jcm8020138
13
Lulu Rong, Bingzhi Wang, Lei Guo, Xiuyun Liu, Bingning Wang, Jianming Ying, Liyan Xue, Ning Lu. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese populationDiagnostic Pathology 2020; 15(1) doi: 10.1186/s13000-020-00950-y
14
Haowen Tang, Wenping Lu, Bingmin Li, Chonghui Li, Yinzhe Xu, Jiahong Dong. Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisOncotarget 2017; 8(22): 36857 doi: 10.18632/oncotarget.16143
15
Shijie Sheng, M. Margarida Bernardo, Sijana H. Dzinic, Kang Chen, Elisabeth I. Heath, Wael A. Sakr. Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature reviewCancer and Metastasis Reviews 2018; 37(4): 655 doi: 10.1007/s10555-018-9767-4
16
Hayley Pye, Mohammed Adil Butt, Laura Funnell, Halla W. Reinert, Ignazio Puccio, Saif U. Rehman Khan, Savvas Saouros, Jared S. Marklew, Ioanna Stamati, Maryam Qurashi, Rehan Haidry, Vinay Sehgal, Dahmane Oukrif, Michael Gandy, Hayley C. Whitaker, Manuel Rodriguez-Justo, Marco Novelli, Rifat Hamoudi, Gokhan Yahioglu, Mahendra P. Deonarain, Laurence B. Lovat. Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expressionOncotarget 2018; 9(33): 22945 doi: 10.18632/oncotarget.25159
17
Anna D. Wagner, Berna C. Özdemir, Josef Rüschoff. Human epidermal growth factor receptor 2-positive digestive tumorsCurrent Opinion in Oncology 2019; 31(4): 354 doi: 10.1097/CCO.0000000000000544